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Abstract
Objective: To assess the characteristics of alcohol and drug 
users who seek treatment at the Brazilian Unified Health System 
in Brazil.
Method: A multicenter cross-sectional study involving five clini-
cal and research centers located in four Brazilian state capitals 
was conducted with 740 in- and outpatients. The only exclusion 
criterion was the presence of neurological or severe psychiatric 
symptoms at the moment of the interview. The Addiction Se-
verity Index (ASI-6) and the Alcohol, Smoking and Substance 
Involvement Screening Test (ASSIST) were used to assess the 
severity of substance use and the problems related.
Results: There were significantly more men than women in the 
sample; mean age was 36 years. The drug most frequently used 
at all sites was alcohol (78%), followed by cocaine/crack (51%). 
Alcohol was the drug that most commonly motivated treatment 
seeking, at all centers. ASI-6 Summary Scores for Recent Func-
tioning (SS-Rs) were quite similar among centers. SS-Rs were 
compared between users who had never received treatment for 
psychoactive substance abuse (n = 265, 36.1%) and those who 
had already been treated at one or more occasions (n = 470, 
63.9%). This analysis revealed significant differences between 
the groups in the drug, psychiatric symptoms, legal, and family/
social problems areas (p < 0.05).
Conclusion: Our findings confirm previous evidence suggesting 
that the management of patients seeking drug abuse treatment 
should take several different aspects into consideration, e.g., 
education, employment, and family relationships, which often 
appear as areas of concern for these individuals.
Keywords: Substance abuse, treatment, multicenter, alcohol, 
drugs, public health.
Resumo
Objetivo: Avaliar as características dos usuários de álcool e dro-
gas que procuram tratamento no Sistema Único de Saúde.
Método: Estudo transversal multicêntrico envolvendo cinco cen-
tros clínicos/de pesquisa localizados em quatro capitais brasi-
leiras foi realizado com 740 pacientes hospitalizados e ambula-
toriais. O único critério de exclusão foi a presença de sintomas 
neurológicos ou psiquiátricos graves no momento da entrevista. 
A Escala de Gravidade de Dependência (Addiction Severity In-
dex, ASI-6) e o teste ASSIST (Alcohol, Smoking and Substance 
Involvement Screening Test) foram utilizados para avaliar a se-
veridade do uso de substância e problemas relacionados.
Resultados: Houve significativamente mais homens do que mu-
lheres na amostra; a idade média foi de 36 anos. A droga mais 
usada em todos os centros foi o álcool (78%), seguido de cocaína/
crack (51%). O álcool foi a droga que mais motivou procura por 
tratamento, em todos os centros. Os Escores Resumidos da ASI-6 
para Funcionamento Recente (SS-Rs) foram bastante similares 
nos centros. SS-Rs foram comparados entre usuários que nunca 
haviam recebido tratamento para abuso de substâncias (n = 265, 
36,1%) e aqueles que já haviam sido tratados uma ou mais ve-
zes (n = 470, 63,9%). Foram observadas diferenças significativas 
entre os grupos nas áreas de droga, sintomas psiquiátricos e pro-
blemas legais e familiares/sociais (p < 0,05).
Conclusões: Nossos dados confirmam evidências prévias de 
que o manejo de pacientes que procuram tratamento para abuso 
de substância deve levar em conta vários aspectos, como edu-
cação, emprego e relações familiares, que normalmente geram 
preocupação nesses indivíduos.
Descritores: Abuso de substâncias, tratamento, multicêntrico, 
álcool, drogas, saúde pública.
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Introduction
Psychoactive drug consumption has become a 
serious problem in developing countries. In Brazil, the 
largest country in Latin America, reported prevalence 
rates of alcohol and drug abuse vary across studies, but 
one common finding is the high lifetime prevalence of 
use of any drug or alcohol, reaching 22.8 and 74.6%, 
respectively.1 In the last decade, epidemiological 
studies conducted in Brazil have reported an increase 
in lifetime consumption of alcohol, tobacco, marijuana, 
inhalants, cocaine, and other drugs.1,2 Such a scenario 
has implications not only for the individual user, in terms 
of psychological and social problems, but also for the 
society at large, in terms of the significant economic 
impact associated with drug abuse.3
In response to the increased prevalence of psychoactive 
drug abuse, there is a growing interest in variables that 
may influence treatment effectiveness.4-7 For example, 
active participation in treatment has been associated 
with positive outcomes among psychoactive drug users.8 
However, many drug users do not even start treatment, 
many leave treatment prematurely, or yet relapse 
following treatment completion.5 In this context, several 
authors have focused on addictive behaviors and tried to 
better understand the factors that motivate individuals to 
seek treatment for substance abuse,5 as well as barriers 
to treatment-seeking7 and outcome predictors.4
In spite of many scientific efforts, a number of 
questions still remain unclear, especially regarding access 
to treatment, treatment compliance, and treatment 
effectiveness. In Brazil, some studies have assessed 
drug abuse characteristics in the general population, 
however only a few have involved clinical samples.2,9 
Among the limitations commonly mentioned by Brazilian 
investigators, political and logistical issues stand out, 
including limited funding and staff, which result in small 
or nonrepresentative samples and directly affect the 
quality of research. According to some authors, this 
scenario can be explained by the recent history of drug 
use research in developing nations.10 Finally, research 
conducted in large countries, such as Brazil, have the 
additional limitation of dealing with cultural and social 
differences as a result of data collection at different sites.
Having an improved knowledge of the profile of 
patients seeking treatment for substance abuse is 
extremely important to ensure adequate treatment 
planning. For instance, many treatment seekers 
have psychiatric comorbidities, use multiple drugs 
concurrently, or present deficits in several areas of their 
lives. An English study that evaluated the profile of 
treatment-seeking drug users found a higher prevalence 
of psychiatric disorders among multiple drug users, 
and also revealed that female gender, physical health, 
interpersonal relationships, and drug dependence are 
important predictors of psychiatric symptoms.11
Currently, drug abuse treatment in Brazil is available to 
the population free of charge via the National Unified Health 
System. Treatment is offered at psychosocial care centers 
specialized in alcohol and drug abuse, private clinics, and 
specialized hospitals. Patients are referred to these different 
levels of care according to abuse severity.12,13 In addition, 
nationwide preventive and treatment programs are often 
implemented by the government. Still, very little is known 
about the profile of patients that seek and benefit from 
these initiatives, about their reasons motivating treatment 
seeking, and about the severity of problems related to drug 
abuse in different Brazilian regions.
Therefore, the objectives of the present study were to 
assess the characteristics of alcohol and drugs users who 
seek treatment at the Brazilian Unified Health System in 
four Brazilian states, with a focus on addiction severity 
and the drug that motivated treatment seeking.
Methods
This was a multicenter cross-sectional study involving 
five research centers located in four Brazilian state capitals.
Data collection sites
The data collection sites were strategically chosen 
due to their previously reported ability to conduct large 
studies in the field and are described below:
- The Center for Drug and Alcohol Research (Centro 
de Pesquisa em Álcool e Drogas, CPAD), at the 
Universidade Federal do Rio Grande do Sul (UFRGS), 
was the coordinating center for this study.
- The Drug Dependence Unit (Unidade de Dependência 
de Drogas, UDED), a section of the Department of 
Psychobiology of the Universidade Federal de São 
Paulo (UNIFESP).
 -The Women’s Drug Dependent Treatment Center 
(Programa de Atenção à Mulher Dependente Química, 
PROMUD), affiliated with the Medical School of 
Universidade de São Paulo (USP). Provides treatment 
mostly for women.
- The Research and Assistance Program in Drug 
Addiction (Programa de Estudos e Assistência ao 
Uso Indevido de Drogas, PROJAD), affiliated with the 
Universidade Federal do Rio de Janeiro.
- The Center for Drug Abuse Studies and Therapy (Centro 
de Estudos e Terapia do Abuso de Drogas, CETAD), a 
permanent extension of the Department of Pathology 
at the Universidade Federal da Bahia (UFBA).
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The SS-Rs are standardized T-scores with a mean of 
50 and a standard deviation of 10, and may range 
from 0 to 100, where higher scores indicate greater 
severity.14
- The Alcohol, Smoking and Substance Involvement 
Screening Test (ASSIST), developed by a team 
of investigators supported by the World Health 
Organization to detect substance use and abuse, 
and validated for Brazilian Portuguese.15 The ASSIST 
instrument has shown high sensitivity and specificity 
for the detection of alcohol, cannabis and cocaine 
abuse/dependence, in addition to high reliability 
(Cronbach’s alpha of 0.80 for alcohol, 0.79 for 
cannabis, and 0.81 for cocaine).15
Interviewers
All the 25 interviewers involved in the study graduated 
psychologists. Interviewer selection was based on the 
candidate’s abilities in multiple areas, including: a) 
experience in dealing with sensitive questions, such as 
drug use and its consequences; b) comprehension of 
research principles and experience in obtaining informed 
consent; c) interest in the objectives of the study; and 
d) ability to apply a structured interview.
Logistics and quality control
The quality of the data collected was ensured 
mostly via training, supervisory oversight, and support 
provided to the field interviewers (psychologists) by 
the research center coordinators. Throughout data 
collection, a weekly meeting was held with the co-PI 
(FK) of each data collection site to oversee the data 
collection process and solve logistical problems. After 
data collection, each site was responsible for sending 
the original questionnaires to the coordinating center in 
Porto Alegre, state of Rio Grande do Sul (CPAD/UFRGS), 
where all data were entered into a single database. On a 
weekly basis, the PI (FP) called or emailed the co-PIs to 
discuss patient recruitment and solve problems related 
to data collection.
Statistical analysis
Data were entered into an Access database and 
analyzed using the Statistical Package for the Social 
Sciences (SPSS) version 16.0. Categorical variables 
were described as absolute frequencies and percentages. 
Quantitative variables with a symmetrical distribution 
were described as means and standard deviation, and 
those with an asymmetrical distribution were presented 
as medians and interquartile ranges.
Referrals from other treatment locations were also 
analyzed by all data collection sites.
Sample selection
Between January and November 2007, a target 
sample of 740 subjects was obtained. Patients were either 
under assessment or already being treated for substance 
abuse or dependence on an inpatient (first 15 days after 
admission) or outpatient (first 10 days) basis. The goal 
was to interview 150 subjects at each study center.
Patients were included in the study if they had used 
alcohol or drugs in the 30 days preceding the interview. 
The only exclusion criterion was the presence of 
neurological or severe psychiatric illness with symptoms 
at the moment of the interview, ascertained by trained 
clinical interviewers. Regarding data collection at all 
centers, seven patients were not included in the sample 
due to severe depressive or psychotic symptoms, and 
four patients did not accept to participate in the study. 
The strategy of including patients from both inpatient 
and outpatient treatment regimens was intended to 
generate a heterogeneous sample, with characteristics 
of the typical Brazilian population who seeks specialized 
treatment for alcohol and drug abuse.
Instruments
The following instruments were used to assess 
patients: 
- Sixth version of the Addiction Severity Index (ASI-
6), a multidimensional semistructured interview 
lasting between 45 and 90 minutes. In the present 
study, a validated Brazilian Portuguese version 
of the instrument was used. The instrument 
assesses the patient’s lifetime and recent status 
in seven functional areas or subscales, namely, 
medical status, employment and support, legal 
status, family and social status, psychiatric status, 
alcohol use, and drug use. Presently, one set of 
summary scores is available, the ASI-6 Summary 
Scores for Recent Functioning (SS-Rs), comprised 
of nine subscales covering status/functioning in 
the past 30 days, provides objective information 
by combining rational and empirical methods. 
The SS-Rs are psychometrically derived using 
the nonparametric item response theory (NIRT) 
and classical psychometric methods; they are 
standardized scores and thus have the advantage 
of reducing the extent of skewness in scores. One 
score is generated for each area/subscale, except 
for the family/social area, in which three scores are 
generated (problems, support, and child problems). 
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of white ethnicity. Education level was significantly lower 
at the PROMUD center. Unemployment was higher at the 
UDED center, however without a significant difference 
when compared with the other centers.
Categorical variables are expressed as absolute 
frequencies and percentages. Quantitative variables 
with a symmetrical distribution are expressed as means 
and standard deviation. Variables with an asymmetrical 
distribution are expressed as medians and interquartile 
ranges. Quantitative variables were compared using 
analysis of variance (ANOVA), followed by Tukey’s test; 
categorical variables were analyzed by chi-square test and 
multiple comparisons, and asymmetrical by Kruskal-Wallis.
The drug most frequently used at all sites was alcohol, 
followed by cocaine/crack. Marijuana was the third 
most frequent drug, and its use was more pronounced 
at CETAD, in the state of Bahia. Other psychoactive 
substances were homogeneously used across the 
centers, except for inhalants, which were more prevalent 
at PROJAD, in Rio de Janeiro (Table 2).
Ethical considerations
All patients were submitted to standard informed consent 
procedures and were only allowed to sign the consent 
forms after a thorough review of patients’ rights and of the 
study objectives and limitations. The study was approved 
by the Institutional Review Board of Hospital de Clínicas de 
Porto Alegre (HCPA), Brazil, and by the respective boards 
of all centers included in the study. Patients received the 
equivalent of U$ 15 after each interview as a compensation 
for their costs with food and transportation.
Results
Table 1 shows the demographic characteristics of the 
sample. There were significantly more men than women 
in the sample; the mean age was 36 years, but users from 
the CETAD center were younger than those selected at 
other centers. This center also showed a lower prevalence 
CETAD
(BA)
PROJAD
(RJ)
PROMUD
(SP)
UDED
(SP)
CPAD
(RS) p TOTAL
Male sex (%) 85.2a 86.0a 46.2b 88.7a 80.7a < 0.001 78.0
Mean age ± standard deviation 31±12b 37±11ac 40±12c 36±10c 36±12a < 0.001 36±12
Income (R$* - past 6 months) 4,000
(1,835-
8,400)bd
2,400
(1,000-
5,000)ae
2,400
(1,508-
4,900)be
5,500
(2,956-
8,700)cd
3,000
(1,237-
9,700)abce
< 0.001 3,600
(1,600-
7,200)
Steady partner (%) 35.0a 33.3ab 20.7b 40.0a 40.0a 0.002 34
White ethnicity (%) 20.1b 47.3a 59.1ac 72.3c 62ac < 0.001 52.5
Outpatient treatment (%) 46.3de 35.1be 97.3a 65.8c 57acd < 0.001 60.5
Elementary and high school (%) 80.7a 62.7cd 56.7bc 77.3a 74.7ae < 0.001 70.3
Unemployed (%) 43.3ab 51.3a 57.3a 34b 50.7a 0.001 47.4
CETAD (BA) = Center for Drug Abuse Studies and Therapy (Bahia); PROJAD (RJ) = Research and Assistance Program in Drug Addiction (Rio de Janeiro); PROMUD 
(SP) = Women’s Drug Dependent Treatment Center (São Paulo); UDED (SP) = Drug Dependence Unit (São Paulo); CPAD (RS) = Center for Drug and Alcohol 
Research (Rio Grande do Sul).
* R$ = Reais; R$ 2.5 are equivalent to US$ 1.
Results followed by different letters indicate the presence of statistically significant differences.
Table 1 - Sample characteristics of substance abusers who sought treatment (n = 740)
Alcohol/drug use (prior 30 days)
CETAD
(BA)
PROJAD
(RJ)
PROMUD
(SP)
UDED
(SP)
CPAD
(RS) p
All centers
n = 740 (%)
Alcohol 107 (76.4) 127 (84.7) 126 (84.0) 122 (81.3) 122 (81.3) 0.389 604 (81.6)
Marijuana 74 (52.9)a 57 (38.0)ab 48 (32.0)b 61 (40.7)ab 62 (41.3)ab 0.010 302 (40.8)
Sedatives 42 (30.0)b 48 (32.0)b 47 (31.3)b 20 (13.3)a 42 (28.0)b 0.001 199 (26.9)
Cocaine/crack 75 (53.6)ab 87 (58.0)a 62 (41.3)b 76 (50.7)ab 78 (52.0)ab 0.026 378 (51.1)
Stimulants 6 (4.3) 4 (2.7) 5 (3.3) 7 (4.7) 5 (3.3) 0.903 27 (3.6)
Hallucinogens 9 (6.4) 3 (2.0) 2 (1.3) 5 (3.3) 4 (2.7) 0.132 23 (3.1)
Inhalants 2 (1.4)ab 18 (12.0)a 2 (1.3)b 4 (2.7)ab 6 (4.0)ab < 0.001 32 (4.3)
Opiates 1 (0.7) 1 (0.7) 1 (0.7) 2 (1.3) 0 (0) 0.742 11 (1.5)
Table 2 - Use of alcohol and other drugs at the five research centers assessed
Results expressed as number of subjects (%).
CETAD (BA) = Center for Drug Abuse Studies and Therapy (Bahia); PROJAD (RJ) = Research and Assistance Program in Drug Addiction (Rio de Janeiro); PROMUD 
(SP) = Women’s Drug Dependent Treatment Center (São Paulo); UDED (SP) = Drug Dependence Unit (São Paulo); CPAD (RS) = Center for Drug and Alcohol 
Research (Rio Grande do Sul).
Results followed by different letters indicate the presence of statistically significant differences.
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Conversely, severity of problems related to Family/
Social Support showed a significantly lower prevalence 
at CETAD when compared with PROJAD, PROMUD, and 
UDED (Table 4).
Alcohol was the drug that most commonly motivated 
treatment seeking in the sample assessed, at all centers. 
The PROJAD center showed a higher prevalence of 
cocaine and a lower prevalence of crack as the drugs 
that motivated treatment seeking (Table 5).
A final analysis was conducted, using Student’s t 
test, to compare SS-Rs between users who had never 
received treatment for psychoactive substance abuse 
(n = 265, 36.1% of the sample) and those who had 
already been treated for substance abuse at one or more 
occasions (n = 470, 63.9%). This analysis revealed 
significant differences between the two groups in the 
following areas: drug, psychiatric symptoms, legal, and 
family/social problems (p < 0.05).
Table 3 describes the profile of alcohol consumption 
in the sample. There were significant differences in 
relation to years of alcohol use and abuse. CETAD, 
in the state of Bahia, showed the lowest time of 
alcohol use (in years), while PROJAD and PROMUD 
presented the highest results for this variable. The 
CPAD center also showed the lowest results for alcohol 
use, although differences were not significant. Alcohol 
use and binge drinking were higher at PROJAD and 
PROMUD when compared to the other centers. Drug 
use among alcohol users was more prevalent at 
CETAD.
In the analysis of SS-Rs, the family/child subscale 
presented higher results at the CPAD when compared 
with the other centers (significant differences in 
relation to PROJAD, PROMUD, and UDED). Also, there 
was a lower prevalence of legal problems at both sites 
located in the state of São Paulo (PROMUD and UDED). 
Variables
CETAD 
(BA)
PROJAD 
(RJ)
PROMUD 
(SP)
UDED 
(SP)
CPAD 
(RS) p
All centers
n = 740 (%)
Years of alcohol use* 3 (0-13)a 11 (2-20)b 10 (3-20)b 5 (0-16)ac 9 (0-20)abc < 0.001 8 (0-18)
Years of alcohol abuse† 2 (0-8)c 9 (1-18)b 7 (1-15)ab 4 (0-15)ac 3 (0-14)ac < 0.001 5 (0-15)
Alcohol use (days)‡ 8 (1-15)a 15 (3-30)b 10 (3-23)ab 8 (1-24)ab 7 (1-25)ab 0.003 10 (1-23)
Binge drinking (days)‡ 4 (0-13)a 15 (1-29)b 8 (0-20)ab 3 (0-19)a 3 (0-20)a < 0.001 5 (0-20)
Years of drug use* 5 (0-10)a 10 (0-15)b 5 (0-15)ab 8 (0-15)ab 7 (0-13)ab 0.048 7 (0-14)
Concomitant use of drugs‡ 13 (1-27)a 8 (0-26)ab 2 (0-15)b 7 (0-28)ab 8 (0-28)ab 0.006 7 (0-25)
Table 3 - Characteristics of alcohol use at the five research centers assessed
Results expressed as medians (interquartile ranges). 
CETAD (BA) = Center for Drug Abuse Studies and Therapy (Bahia); PROJAD (RJ) = Research and Assistance Program in Drug Addiction (Rio de Janeiro); PROMUD 
(SP) = Women’s Drug Dependent Treatment Center (São Paulo); UDED (SP) = Drug Dependence Unit (São Paulo); CPAD (RS) = Center for Drug and Alcohol 
Research (Rio Grande do Sul).
* 3 times per week or more; † 5 drinks per day or more; ‡ in the preceding 30 days.
Results followed by different letters indicate the presence of statistically significant differences.
SS-R subscales
CETAD 
(BA)
PROJAD 
(RJ)
PROMUD 
(SP)
UDED 
(SP)
CPAD 
(RS) p
All centers
n = 740 (%)
Drug 49.8±10.4a 47.4±10.8ab 45.5±11.2b 47.8±12.0ab 49.1±11.5a 0.012 47.9±11.3
Family/child 52.9±8.1ac 51.5±7.5a 51.2±7.1a 49.6±5.3d 54.8±9.3bc < 0.001 52.0±7.7
Alcohol 53.9±10.3a 56.9±9.4ab 57.3±9.8b 55.2±11.0ab 56.0±10.5ab 0.033 55.8±10.3
Psychiatric 48.4±7.7a 51.2±8.4a 50.0±8.4ab 50.6±8.4ab 51.5±8.7b 0.017 50.4±8.4
Medical 45.5±8.6a 49.0±8.5b 45.2±10.1a 44.3±10.6a 49.2±9.1b < 0.001 46.6±9.6
Legal 51.2±7.7a 51.8±6.9a 47.6±4.8b 47.8±4.9b 51.0±7.3a < 0.001 49.9±6.7
Employment 40.5±11.1a 45.9±9.3b 43.7±10.1a 39.8±11.6a 42.7±10.8ab < 0.001 42.6±10.8
Family/social support 43.2±10.2a 47.5±10.1bc 47.2±11bd 47.8±10.8cd 44.5±9.8ab < 0.001 46.1±10.5
Family/social problem 56.4±9.0a 54.9±8.5acd 53±10.3bc 52.1±8.8bd 56.7±9.5a < 0.001 54.7±9.3
Table 4 - Summary scores of the Addiction Severity Index (SS-Rs, ASI-6) obtained at the five research centers involved
Results expressed as mean ± standard deviation.
CETAD (BA) = Center for Drug Abuse Studies and Therapy (Bahia); PROJAD (RJ) = Research and Assistance Program in Drug Addiction (Rio de Janeiro); PROMUD 
(SP) = Women’s Drug Dependent Treatment Center (São Paulo); UDED (SP) = Drug Dependence Unit (São Paulo); CPAD (RS) = Center for Drug and Alcohol 
Research (Rio Grande do Sul).
Results followed by different letters indicate the presence of statistically significant differences.
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use.18 A Brazilian study of female alcohol users treated at 
a specialized outpatient clinic showed that most of them 
presented severe dependence.19
The mean age of our sample is in line with the 
relevant literature, which shows that substance abusers 
tend to seek treatment later in life than individuals with 
other psychiatric disorders, probably as a result of a 
higher number of barriers to treatment initiation.7 In 
turn, the higher mean age observed in our patients when 
compared with samples of non-alcohol drug users may 
be explained by the high rates of alcohol use and abuse 
observed in our study, as problems alcohol-related 
problems tend to manifest later in life.20,21 Moreover, our 
results showed a tendency to lower alcohol consumption 
and increased marijuana consumption in the state of 
Bahia (CETAD) when compared with the other centers, 
which may also be associated with the younger sample 
recruited at that center.
We found a low rate of patients living with a partner, 
which probably reflects the difficulties of living with 
a drug addict. This finding was also more common 
among PROMUD patients, which is consistent with 
other Brazilian studies that suggest a low tolerance 
among males toward female drug-dependent partners.22 
Conversely, there is also evidence that a family 
environment marked by neglect, abandonment, physical 
abuse and lack of dialogue is associated with initiation of 
drug use.23 Therefore, it is difficult to know whether the 
dysfunctional relationships commonly observed among 
drug users are caused by drug abuse per se or whether 
they are a consequence of dysfunctional family patterns.
As expected, patients recruited at CETAD, the only 
research center located in the state of Bahia, northeast 
Brazil, differed from the remainder of the sample with 
regard to ethnicity: CETAD patients were predominantly 
Afro-Brazilian, compared to a majority of Caucasians 
selected at the other regions. According to the Brazilian 
Discussion
The present study assessed the profile of drug 
abuse treatment seekers selected at five research 
centers located in four Brazilian states. Based on the 
data collected, we believe that the main goal of our 
study was met, namely, to improve our knowledge of 
the characteristics of alcohol and drugs users seeking 
treatment at the Brazilian public health system, of the 
severity of problems related to drug abuse, and of 
the main drug motivating treatment seeking. Patients 
selected at the four Brazilian states were similar, 
suggesting that our sample was representative of 
the general population of treatment seekers in Brazil, 
although some distinguishing features will be addressed 
below. In addition, our findings highlight the complexities 
involved in substance abuse treatment, with several 
variables influencing treatment planning and patient 
management. Such a complex scenario includes both 
individual variables (e.g., the presence of comorbidities 
and addition severity) and also environmental factors 
(e.g., characteristics of the health care system, social/
family support, etc.).
As mentioned above and shown in Table 1, the 
samples selected at all participating centers were 
similar and heterogeneous in terms of demographic 
characteristics – even at PROMUD, a center that 
provides treatment mostly to female patients at an 
outpatient basis. A predominance of male patients has 
been reported in previous substance abuse studies and 
at specialized treatment facilities. Women, in turn, are 
known to more frequently seek help for the treatment 
of alcohol use and mental health problems,16 but the 
stigma that still surrounds addicted women often delays 
or hinders their decision to seek treatment.17 Also, the 
fact that women usually report worse social support 
than men could influence the severity of their substance 
First, second or third drug motivating 
treatment seeking
CETAD
(BA)
PROJAD
(RJ)
PROMUD 
(SP)
UDED
(SP)
CPAD
(RS) p
All centers
n = 740
Alcohol 48.3a 67.5b 70.3b 56.6ab 58.0ab 0.001 60.2
Marijuana 32.2a 27.2ab 16.6b 29.6ab 23.3ab 0.024 25.8
Cocaine 32.2a 58.9b 29.7a 40.8a 31.3a < 0.001 38.7
Crack 35.7a 8.6b 24.1a 25.7a 37.3a < 0.001 26.2
Stimulants, sedatives 2.8 3.3 6.9 2.6 6.0 0.233 4.3
Other drugs 18.9ac 45.7b 12.4a 27.0c 21.3ac < 0.001 25.2
Anything 2.1 2.6 0 2 0.7 0.299 1.5
Table 5 - Drugs motivating treatment seeking at the different centers assessed
Results expressed as number of subjects (%).
CETAD (BA) = Center for Drug Abuse Studies and Therapy (Bahia); PROJAD (RJ) = Research and Assistance Program in Drug Addiction (Rio de Janeiro); PROMUD 
(SP) = Women’s Drug Dependent Treatment Center (São Paulo); UDED (SP) = Drug Dependence Unit (São Paulo); CPAD (RS) = Center for Drug and Alcohol 
Research (Rio Grande do Sul).
Results followed by different letters indicate the presence of statistically significant differences.
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2). The CETAD center showed the highest prevalence 
of marijuana use, which highlights the influence of 
cultural factures on the choice of drugs. Marijuana 
was introduced and distributed in Brazil through 
the Atlantic slave trade, which brought people from 
Africa in ships that reached mainly the state of Bahia, 
in the northeastern Brazilian coast. Some authors 
hypothesize that the high prevalence of marijuana use 
and abuse currently observed in the state of Bahia 
is still a legacy of that period.29 Similarly, the high 
rate of inhalant use obtained in the PROJAD sample 
may suggest either a sample selection bias or a local 
cultural specificity in Rio de Janeiro.
The high rate of binge drinking found in the PROJAD 
sample (Table 3) confirms a consumption pattern that 
had already been reported among Brazilian youths 
and adults.30,31 According to the National Institute on 
Alcohol Abuse and Alcoholism, the concept of binge 
drinking or “heavy episodic drinking” emerged based 
on evidence suggesting an increased risk of problems 
associated with the consumption pattern, and is defined 
as the consumption of five or more alcoholic drinks 
for men and four or more drinks for women on one 
occasion. One-fourth of alcohol users drink excessive 
quantities of alcohol and present binge drinking-related 
problems.32 A Brazilian study conducted with 2,346 
individuals aged 18 years or more showed that 28% 
regularly binge drank, and 25% reported at least one 
problem related to this behavior.33
In the last decade, an increase in cocaine 
consumption has been documented in Brazil, both in the 
general population and among students, as a result of an 
increasingly widespread use of crack.1,34-36 The barriers 
and difficulties faced by the Brazilian public health 
system to accommodate the needs of cocaine- and 
crack-dependent patients under treatment, especially 
as a result of the closure of psychiatric beds, are well 
known.37,38 However, the majority of studies conducted 
in other countries to analyze the characteristics of 
treatment seekers have focused predominantly on 
alcohol abusers or cocaine snorters.39,40 Therefore, 
there is a lack of studies assessing the characteristics of 
crack users and the role of crack as the drug motivating 
treatment seeking.
In our sample, crack use was one of the main 
reasons leading people to seek treatment. At the CPAD 
center, crack was the drug that motivated treatment 
seeking for almost half of the sample; in the remainder 
of the sample, crack use accounted for at least 30% 
of the drugs motivating treatment seeking (Table 5). 
The typical crack user has been defined as a youth, 
unemployed, coming from a broken family, presenting 
with other psychiatric comorbidities and reporting 
Institute of Geography and Statistics, about 78% of 
the population in Bahia is Afro-Brazilian. Again, this is 
an example of the typical variability faced by studies 
conducted in large countries such as Brazil and justifies 
the inclusion of data collection sites located in different 
regions in order to broaden the validity of the study.24 
However, in spite of the ethnic differences observed 
across the centers involved, the severity of problems 
related to the use of drugs was very similar in the 
different regions assessed.
Overall, the sample showed high education levels when 
compared to the general Brazilian population. Education 
level has long been associated with social and economic 
status in Brazil. As a result of flaws in the Brazilian public 
health system, individuals with better financial conditions 
tend to better identify and find treatment facilities, which 
probably explains the higher education rates found in our 
sample. Also, although education is known to be higher 
among women in Brazil, our study found lower results at 
the PROMUD center, where mostly women are treated. 
This finding may be the result of specific characteristics 
of the patients treated at that center, but it underscores 
the importance of studying the characteristics of drug 
users and to investigate how this population differs 
from non-drug users. A study conducted in the United 
States showed an association between poor literacy and 
higher rates of depressive symptoms in an alcohol- and 
drug-dependent population.25 Our study did not confirm 
those findings, but the PROJAD center, located in Rio de 
Janeiro, interestingly showed the lowest education levels 
and also the highest rates of psychiatric symptoms.
Our sample also showed a higher rate of 
unemployment (47.4%) when compared to data 
available for the general Brazilian population. Official 
data for 2008 reveal much lower unemployment rates 
in Brazil, as low as 9.8%, which points to the severity of 
problems related to drug abuse, including poverty and 
a circular cause and effect relationship involving job-
seeking and unemployment among drug/alcohol users.26
Previous studies have shown high severity scores 
in many areas of the ASI-6 related to alcohol and drug 
use in individuals seeking specialized treatment.27 Our 
sample showed a high prevalence of alcohol-related 
problems: 81% of the subjects had consumed alcohol 
in the 30 days preceding the interview (Table 2), and 
most reported alcohol abuse for about 5 years (Table 
3). According to Caetano & Laranjeira, several factors 
contribute to the high rates of alcohol use observed in 
Brazil, e.g., the expansion of local alcohol industries as a 
result of socioeconomic growth, massive advertising, low 
pricing and the lack of adequate consumption policies.28
A substantial percentage of the sample used 
marijuana in the 30 days preceding the interview (Table 
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suggest that the pattern of drug consumption in general 
and of crack consumption in particular in Brazil may 
be different from (and significantly higher than) that 
in other countries. Finally, the increasing mortality 
rates associated with crack use in young populations 
further underscores the severity of the crack epidemic 
in Brazil.49
In 2008, a sample of female patients seeking 
treatment for alcoholism was assessed for differences 
between early dropout and non-dropout patients. 
The study did not identify any social or demographic 
factor significantly associated with early dropout, but 
suggested an association of the latter with the pattern 
of alcohol consumption.50 Another study assessing a 
population of female drug users undergoing psychiatric 
treatment in São Paulo showed that representations on 
the use of alcohol in these women were linked to family, 
profession and gender issues, indicating that the search 
for treatment was not only motivated by substance use 
per se, but by all areas affected by such use.51
Our findings confirm previous evidence suggesting 
that the management of patients seeking drug abuse 
treatment should take several different aspects into 
consideration, e.g., education, employment, and family 
relationships, which often appear as areas of concern 
for these individuals; however, little information is 
available on the severity and impairment associated 
with drug use in these areas.52 Several treatment 
programs tend to focus on reducing drug use and ignore 
the psychosocial problems underlying the patient’s 
decision to seek assistance. Initiatives that do not 
prioritize patient’s needs commonly have higher rates 
of treatment noncompliance.5
Finally, another aspect that should be taken into 
consideration is that the specific characteristics of the 
health care services sought by drug users may also 
influence their decision to seek treatment. Such aspects 
may include political issues (e.g., the funding received 
by each service) and also characteristics of each 
individual treatment program (e.g., complex admission 
criteria, absence of appropriate services for groups such 
as women, waiting lists, and lack of cooperation across 
service organizations).7 Therefore, further studies should 
be carried out with the aim of providing a detailed profile 
of the health care services available for drug users in 
Brazil, with a focus on identifying variables that may 
influence specialized treatment seeking.
In sum, efforts should continue to be directed toward 
the identification and understanding of populations 
at greater risk for drug abuse, and to the continuou 
improvement of our knowledge of addictive behaviors 
in Brazil and in the world. Taken together, these data 
could be extremely useful for the development of cost-
concomitant use of other drugs. Crack use has been 
implicated in increased mortality rates among young 
people, especially as a result of crime and AIDS 
infection.41-44 Our results corroborate these findings: 
our PROJAD sample included the highest number of 
crack users and also presented the highest rate of legal 
problems (Table 4).
The results obtained for crack use in our sample 
underscore the current need to study the severity of 
problems related to the use of this particular drug. Crack 
was the second major drug motivating treatment seeking 
in our sample, a striking finding in view of the scarcity of 
information available on this drug in Brazil. Nevertheless, 
our results contribute to a better understanding of the 
profile of crack users and of their major concerns and 
reasons for seeking treatment, and therefore can be 
useful for the planning of therapeutic strategies.
The analysis of SS-Rs suggests that the differences 
observed across centers are the result of demographic 
and cultural factors that are inherent to studies 
conducted in large countries. In addition, none of 
the differences observed on SS-Rs reached statistical 
significance. Nevertheless, previous similar studies 
have used different versions of the ASI-6, which 
impeded the comparison of our data with the literature. 
Future studies are therefore needed to determinate 
whether or not our results can be generalized to other 
populations of drug users as well as to drug users not 
seeking treatment.
The severity of problems related to substance 
abuse is poorly understood in Brazil, but has been 
described in several studies conducted worldwide. U.S. 
studies have suggested a possible association between 
traumatic events in childhood and increased drug 
abuse severity, in addition to a greater vulnerability to 
relapse in this subgroup of patients.45,46 Another study 
conducted in India in 2003 showed that individuals 
seeking treatment for substance abuse, especially 
those presenting with psychiatric comorbidities, have 
a higher risk of contracting HIV.47 Similar findings have 
been reported in Brazil.48
Another important issue in this scenario is the 
possible relationship between substance abuse-
related problems and the patients’ reasons for seeking 
treatment. There is evidence that physical symptoms 
such as abstinence-related pain often motivate seeking 
treatment.18 A Canadian study has shown that, in a 
population of alcohol abusers, those with a diagnosis 
of dependence were more likely to seek treatment, 
suggesting an influence of severity of dependence on 
this outcome.39 However, most studies so far have 
been performed in populations with low rates of crack 
abuse when compared with Brazil. This difference may 
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effective interventions aimed at increasing treatment 
seeking and treatment compliance rates, consequently 
decreasing relapse and reducing the social and financial 
costs involved in the treatment of substance abuse.
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